Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_734_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Disclaimer
- •Contents
- •Contributors
- •Embryology
- •Lymphatics
- •Nerves
- •Clinically Relevant Anatomic Variations
- •Duodenum Inversum
- •Pancreas Divisum
- •Annular Pancreas
- •Ectopic Pancreas
- •Ansa Pancreatica
- •Pancreaticobiliary Maljunction
- •Duplication Anomalies
- •Physiology
- •Duodenal Physiology
- •Mechanical Function
- •Endocrine Function
- •Pancreatic Physiology
- •Exocrine Physiology
- •Normal Anatomy
- •Duodenal Anatomy
- •Pancreatic Anatomy
- •Ductal Anatomy
- •Vasculature
- •Endocrine Physiology
- •References
- •Etiology
- •Pathophysiology
- •Diagnosis
- •Clinical Presentation
- •Laboratory Tests
- •Imaging
- •Medical Management
- •Fluid Resuscitation
- •Analgesics
- •Prophylactic Antibiotics
- •Nutrition
- •Complications
- •Long-Term Sequelae of Acute Pancreatitis
- •References
- •Introduction
- •Initial Treatment
- •Reducing Severity of Acute Pancreatitis
- •Fluid Resuscitation
- •Pain Management
- •Nutrition
- •Preventing Infectious Complications
- •References
- •Introduction
- •Sterile Pancreatic Necrosis
- •Antibiotic Therapy
- •Catheter Drainage
- •Video-Assisted Retroperitoneal Drainage (VARD) Procedure
- •Sinus Tract Necrosectomy
- •Open Necrosectomy
- •Open Trans-Gastric Cystogastrostomy
- •Disconnected Distal Pancreatic Duct Syndrome
- •Introduction
- •References
- •Introduction
- •Venous Thrombosis
- •Intra-Abdominal Hypertension
- •Thoracic Complications
- •Gastrointestinal Complications
- •References
- •Pain
- •Endocrine Dysfunction
- •Exocrine Dysfunction
- •Conclusion
- •References
- •Background
- •Postoperative Care
- •References
- •Background
- •Head-Dominant Disease
- •Tail-Dominant Disease
- •Perioperative Management
- •Procedure Steps
- •Open Whipple
- •MIS Whipple
- •Open Distal Pancreatectomy
- •MIS Distal Pancreatectomy
- •Pearls
- •References
- •Introduction
- •Procedures
- •Indications
- •Contraindications
- •Preoperative Workup
- •Pediatrics
- •Patient Selection
- •Contraindications
- •Key Steps
- •Common Steps
- •Pitfalls/Tricks
- •Local Complications
- •Systemic Complications
- •References
- •History/Introduction
- •Indications
- •Adults
- •Procedural Aspects
- •Preoperative Care
- •Total Pancreatectomy
- •Islet Infusion
- •Minimally Invasive Surgery (MIS)
- •Postoperative Care
- •Outcomes
- •Perioperative Data
- •Perioperative Complications
- •Endocrine Function
- •References
- •Introduction
- •Duodenal Adenomas
- •Duodenal Adenocarcinomas
- •Duodenal Neuroendocrine Tumors (D-NETs)
- •Other Non-neoplastic Epithelial Lesions
- •Duodenal Gastrointestinal Stromal Tumors (DGISTs)
- •Leiomyoma
- •Lipoma
- •Choledochal Cysts
- •Duodenal Lymphoma
- •Conclusion
- •References
- •Introduction
- •Pre-procedural Considerations
- •Indications
- •Resection Techniques
- •Sporadic Non-ampullary Adenomas: Cold Snare Polypectomy
- •Sporadic Non-ampullary Adenomas: EMR
- •Sporadic Non-ampullary Adenomas: ESD
- •Sporadic Non-ampullary Adenomas: Full-Thickness Resection Device
- •Ampullary Adenomas: Endoscopic Papillectomy
- •Sporadic Non-ampullary Adenomas: Cold Snare Polypectomy
- •Sporadic Non-ampullary Adenomas: EMR
- •Endoscopic Papillectomy
- •Surveillance
- •References
- •Introduction
- •Benign Tumors
- •Genetic Syndromes
- •Pre-Malignant Tumors
- •Low-Grade Malignancies
- •Alternatives
- •Inclusion Criteria
- •Preoperative Planning
- •Open Transduodenal Ampullectomy
- •Minimally Invasive (Robotic-Assisted) Transduodenal Ampullectomy
- •Outcomes
- •Conclusions
- •References
- •Introduction
- •Anatomy
- •Laparoscopic Segmental Duodenectomy
- •Robotic Segmental Duodenectomy
- •Technique
- •Open Segmental Duodenectomy
- •Patient Positioning
- •Technique
- •Conclusion
- •References
- •Overview
- •Intraductal Papillary Mucinous Neoplasm (IPMN)
- •General Concepts
- •Novel Biomarkers
- •DNA-Based Biomarkers
- •MiRNA
- •Protein-Based Biomarkers
- •IPMNs
- •MCNs
- •SCNs
- •SPTs
- •Guidelines
- •Surveillance Discontinuation
- •Follow-Up Strategy
- •The Verona Policy
- •Conclusions
- •References
- •Introduction
- •Pathophysiology
- •Work-Up
- •Tissue Diagnosis
- •Serum Tumor Markers
- •Multidisciplinary Decision-Making
- •Adjuvant Trials
- •Systemic Chemotherapy
- •Chemoradiation
- •Neoadjuvant Trials
- •Chemotherapy
- •Chemoradiation
- •Pancreatectomy
- •Summary
- •References
- •Introduction
- •Diagnosis
- •Imaging
- •Functionality
- •Insulinoma
- •Gastrinoma
- •VIPoma
- •Glucagonoma
- •Staging/Surgical Decision-Making
- •Nonmetastatic Disease
- •Metastatic Disease
- •Multidisciplinary Decision-Making
- •Surgical Resection
- •Systemic Treatments
- •Open Trials
- •Surveillance
- •References
- •Renal Cell Carcinoma
- •Introduction/Epidemiology
- •Diagnosis/Radiology/Pathology
- •Treatment/Outcome
- •Colorectal Carcinoma
- •Introduction/Epidemiology
- •Diagnosis/Radiology/Pathology
- •Treatment/Prognosis
- •Melanoma
- •Introduction/Epidemiology
- •Diagnosis/Radiology/Pathology
- •Treatment/Prognosis
- •Sarcoma
- •Introduction/Epidemiology
- •Diagnosis/Radiology/Pathology
- •Treatment/Prognosis
- •Conclusion
- •References
- •Preoperative Considerations
- •Key Steps
- •Staging Laparoscopy
- •Specimen Removal
- •Vascular Resection
- •Reconstruction
- •Pancreaticojejunostomy
- •Hepaticojejunostomy
- •Gastro- or Duodeno-Jejunostomy
- •Final Steps
- •References
- •Randomized Controlled Trials
- •Surgical Technique
- •Resection Phase
- •Reconstruction Phase
- •Postoperative Course
- •Conclusions
- •References
- •Introduction
- •Preoperative Workup
- •Preoperative Planning
- •Surgical Management
- •Patient Preparation
- •Surgical Steps
- •Step 1: Kocher Maneuver
- •Step 4: Pancreatic Transection
- •Reconstruction
- •Hepaticojejunostomy
- •Pancreaticojejunostomy
- •Duodenojejunostomy
- •References
- •Introduction
- •Preoperative Planning
- •Diagnostic Laparoscopy
- •Radical Antegrade Modular Pancreatosplenectomy (RAMPS)
- •Splenic Vein Stump Length
- •Ligamentum Teres/Falciform Pedicle Flap
- •References
- •History
- •Early Exploration
- •Trends Over Time
- •Morbidity
- •Safety
- •Oncologic Safety
- •Preoperative Planning
- •Clinical Considerations
- •Anatomical Considerations
- •Surgical Technique
- •Conclusion
- •References
- •Introduction
- •Indications
- •Preoperative Testing
- •Operative Approach
- •Peritoneal Access
- •Specimen Extraction
- •Closure
- •Clinical Outcomes
- •Conclusions
- •References
- •Introduction
- •Preoperative Preparation
- •Key Shared Operative Steps
- •Trocar Placement
- •Splenic Flexure Mobilization
- •Pancreas Mobilization
- •Identify Pancreatic Pathology
- •Pancreatic Transection
- •Splenic Vein Dissection
- •Splenic Artery Dissection
- •Conclusion
- •References
- •Introduction
- •Historical Evolution
- •Perioperative Outcomes
- •Oncologic Outcomes
- •Neoadjuvant Therapy
- •Preoperative Adjuncts
- •Preoperative Coiling
- •Aortic Stenting
- •Robotic DP-CAR Surgical Technique
- •Positioning
- •Port Placement
- •Surgical Steps
- •Perioperative Care
- •Conclusion
- •References
- •Introduction
- •Preoperative Considerations
- •Laparoscopic Enucleation
- •Patient Positioning
- •Procedure
- •Robotic Enucleation
- •Patient Positioning
- •Procedure
- •Open Enucleation
- •Postoperative Management
- •Postoperative Outcomes
- •References
- •Introduction
- •Indications
- •Preoperative Assessment
- •Serologic Testing
- •Surgical Management
- •Patient Preparation
- •Diagnostic Laparoscopy
- •Surgical Steps
- •Step 1: Gastric Mobilization
- •Step 2: Pancreatic Resection
- •Step 3: Reconstruction
- •Jejunojejunostomy
- •Pancreaticojejunostomy
- •Discussion
- •References
- •Introduction
- •Biliary Obstruction
- •Endoscopic Interventions
- •Plastic Versus Metal Stents
- •Covered Versus Uncovered Metal Stents
- •Stent Obstruction
- •Surgical Options
- •Endoscopic Versus Surgical Intervention
- •Duodenal Obstruction
- •Duodenal Stents
- •Venting Percutaneous Gastrostomy Tubes (PEG)
- •Surgical Gastrojejunostomy (Duodenal Bypass)
- •Endoscopic Versus Surgical Intervention
- •Abdominal Pain
- •Celiac Plexus Neurolysis
- •Surgical Celiac Plexus Block
- •Summary
- •References

324
14. Brozzetti S, Bini S, De Lio N, Lombardo C, Boggi U.Surgical-only treatment of pancreatic
and extra-pancreatic metastases from renal cell carcinoma- quality of life and survival analysis. BMC Surg. 2020;20(1):101.
15. Yoon J, Petrosyan A, Wang T, Ameer A.Colonic adenocarcinoma with synchronous metastasis
to the pancreas: a case report and literature review. JGH Open. 2022;6(4):274–6.
16. Olesinski T, Milewska J, Symonides M, Palucki J, Mróz A, Rutkowski A.Pancreatic metastases
of rectal cancer-case report and literature review. J Gastrointest Cancer. 2019;50(2):338–41.
17. Tani R, Hori T, Yamada M, etal. Metachronous pancreatic metastasis from rectal cancer that
masqueraded as a primary pancreatic cancer: a rare and difcult-to-diagnose metastatic tumor
in the pancreas. Am J Case Rep. 2019;20:1781–7.
18. Su L, Wernberg J.Synchronous distal pancreatic metastatic lesion arising from colonic adenocarcinoma: case report and literature review. Clin Med Res. 2014;12(3–4):166–70.
19. Lee CW, Wu RC, Hsu JT, etal. Isolated pancreatic metastasis from rectal cancer: a case report
and review of literature. World J Surg Oncol. 2010;8:26.
20. McDaniel KP, Charnsangavej C, DuBrow RA, Varma DG, Graneld CA, Curley SA.Pathways
of nodal metastasis in carcinomas of the cecum, ascending colon, and transverse colon: CT
demonstration. AJR Am J Roentgenol. 1993;161(1):61–4.
21. Sano I, Katanuma A, Yane K, etal. Pancreatic metastasis from rectal cancer that was diagnosed by endoscopic ultrasonography-guided ne needle aspiration (EUS-FNA). Intern Med.
2017;56(3):301–5.
22. Pang JC, Roh MH.Metastases to the pancreas encountered on endoscopic ultrasound-guided,
ne-needle aspiration. Arch Pathol Lab Med. 2015;139(10):1248–52.
23. Nakamura Y, Yamada R, Kaneko M, etal. Isolated pancreatic metastasis from malignant melanoma: a case report and literature review. Clin J Gastroenterol. 2019;12(6):626–36.
24. McLoughlin JM, Zager JS, Sondak VK, Berk LB.Treatment options for limited or symptomatic metastatic melanoma. Cancer Control. 2008;15(3):239–47.
25. Nikfarjam M, Evans P, Christophi C. Pancreatic resection for metastatic melanoma. HPB
(Oxford). 2003;5(3):174–9.
26. Sperti C, Polizzi ML, Beltrame V, Moro M, Pedrazzoli S.Pancreatic resection for metastatic
melanoma. Case report and review of the literature. J Gastrointest Cancer. 2011;42(4):302–6.
27. Yagi T, Hashimoto D, Taki K, etal. Surgery for metastatic tumors of the pancreas. Surg Case
Rep. 2017;3(1):31.
28. Rinne D, Baum RP, Hor G, Kaufmann R.Primary staging and follow-up of high risk melanoma
patients with whole-body 18F-uorodeoxyglucose positron emission tomography: results of a
prospective study of 100 patients. Cancer. 1998;82(9):1664–71.
29. Tsitouridis I, Diamantopoulou A, Michaelides M, Arvanity M, Papaioannou S. Pancreatic
metastases: CT and MRI ndings. Diagn Interv Radiol. 2010;16(1):45–51.
30. Franz D, Esposito I, Kapp AC, Gaa J, Rummeny EJ.Magnetic resonance imaging of less common pancreatic malignancies and pancreatic tumors with malignant potential. Eur J Radiol
Open. 2014;1:49–59.
31. Balci NC, Semelka RC. Radiologic features of cystic, endocrine and other pancreatic neoplasms. Eur J Radiol. 2001;38(2):113–9.
32. Fusaroli P, D'Ercole MC, De Giorgio R, Serrani M, Caletti G.Contrast harmonic endoscopic
ultrasonography in the characterization of pancreatic metastases (with video). Pancreas.
2014;43(4):584–7.
33. Vargas-Jiménez J, Vargas-Madrigal J, Arias-Mora R, Ulate-Ovares D, Solis-Ugalde
B. Pancreatic metastasis from malignant melanoma: not all that glitters is gold. Case Rep
Gastroenterol. 2021;15(1):131–6.
34. Yamao K, Sawaki A, Mizuno N, Shimizu Y, Yatabe Y, Koshikawa T.Endoscopic ultrasoundguided ne-needle aspiration biopsy (EUS-FNAB): past, present, and future. J Gastroenterol.
2005;40(11):1013–23.
35. Ohsie SJ, Sarantopoulos GP, Cochran AJ, Binder SW.Immunohistochemical characteristics of
melanoma. J Cutan Pathol. 2008;35(5):433–44.
R. Mudgway et al.

18 Secondary Malignant Neoplasms
36. Birnbaum DJ, Moutardier V, Turrini O, Gonçalves A, Delpero JR.Isolated pancreatic metastasis from malignant melanoma: is pancreatectomy worthwile? J Surg Tech Case Rep.
2013;5(2):82–4.
37. Goyal J, Lipson EJ, Rezaee N, etal. Surgical resection of malignant melanoma metastatic to
the pancreas: case series and review of literature. J Gastrointest Cancer. 2012;43(3):431–6.
38. Wood TF, DiFronzo LA, Rose DM, etal. Does complete resection of melanoma metastatic to
solid intra-abdominal organs improve survival? Ann Surg Oncol. 2001;8(8):658–62.
39. Bassi C, Butturini G, Falconi M, Sargenti M, Mantovani W, Pederzoli P. High recurrence
rate after atypical resection for pancreatic metastases from renal cell carcinoma. Br J Surg.
2003;90(5):555–9.
40. Reddy S, Wolfgang CL.The role of surgery in the management of isolated metastases to the
pancreas. Lancet Oncol. 2009;10(3):287–93.
41. Larsen AK, Krag C, Geertsen P, Jakobsen LP.Isolated malignant melanoma metastasis to the
pancreas. Plast Reconstr Surg Glob Open. 2013;1(8):e74.
42. Schuchter LM, Green R, Fraker D.Primary and metastatic diseases in malignant melanoma of
the gastrointestinal tract. Curr Opin Oncol. 2000;12(2):181–5.
43. Wibmer C, Leithner A, Zielonke N, Sperl M, Windhager R.Increasing incidence rates of soft
tissue sarcomas? A population-based epidemiologic study and literature review. Ann Oncol.
2010;21(5):1106–11.
44. Lee M, Song JS, Hong SM, etal. Sarcoma metastasis to the pancreas: experience at a single
institution. J Pathol Transl Med. 2020;54(3):220–7.
45. Cirotski D, Panicker J. Parosteal osteosarcoma with pancreatic metastasis and multiple
relapses: a case report and review of the literature. Case Rep Oncol. 2021;2021(2):983–8.
46. Chen JJ, Chou CW. A rare case report of mesenchymal chondrosarcoma with pancreatic
metastasis. Medicina (Kaunas). 2022;58(5):639.
47. Ishizaki A, Okuwaki K, Kida M, etal. The rst case of metastatic pancreatic leiomyosarcoma
derived from the urinary bladder diagnosed using an endoscopic ultrasound-guided ne-needle
biopsy. Intern Med. 2021;60(9):1377–81.
48. Chilukuri DS, Premkumar P, Venkitaraman B, Soundararajan JCB. Pancreatic metastasis of
dermatobrosarcoma protuberans: a rare case. BMJ Case Rep. 2020;13(1):e232614.
49. Narayan RR, Charville GW, Delitto D, Ganjoo KN.First recurrence of synovial sarcoma presenting with solitary pancreatic mass. Cureus. 2022;14(6):e26356.
50. Polimera H, Moku P, Abusharar SP, Vasekar M, Chintanaboina J.Metastasis of ewing sarcoma
to the pancreas: case report and literature review. Case Rep Oncol Med. 2020;2020:7075048.
51. Leong SP, Cady B, Jablons DM, etal. Clinical patterns of metastasis. Cancer Metastasis Rev.
2006;25(2):221–32.
52. Pennacchioli E, Tosti G, Barberis M, et al. Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread? Clin Exp Metastasis.
2012;29(7):757–73.
53. Huddy JR, Sodergren MH, Deguara J, Thway K, Jones RL, Mudan
SS. Pancreaticoduodenectomy for the management of pancreatic or duodenal metastases
from primary sarcoma. Anticancer Res. 2018;38(7):4041–6.
54. Nakashima Y, Unni KK, Shives TC, Swee RG, Dahlin DC.Mesenchymal chondrosarcoma of
bone and soft tissue. A review of 111 cases. Cancer. 1986;57(12):2444–53.
55. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, Ferrari S.Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori. 2007;93(5):423–7.
56. Yokoyama Y, Murakami Y, Sasaki M, etal. Pancreatic metastasis of dermatobrosarcoma protuberans. J Gastroenterol. 2004;39(8):798–800.
57. Mahajan BB, Sumir K, Singla M.Metastatic dermatobrosarcoma protuberans: a rare case
report from North India. J Cancer Res Ther. 2015;11(3):670.
58. Spurrell EL, Fisher C, Thomas JM, Judson IR. Prognostic factors in advanced synovial
sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. Ann Oncol.
2005;16(3):437–44.
325

326
59. Bakri A, Shinagare AB, Krajewski KM, etal. Synovial sarcoma: imaging features of common and uncommon primary sites, metastatic patterns, and treatment response. AJR Am J
Roentgenol. 2012;199(2):W208–15.
60. Fletcher CDM, Unni KK, Mertens F, World Health Organization, International Agency for
Research on Cancer. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC
Press; 2002. 427p.
61. Syed M, Mushtaq S, Loya A, Hassan U.NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study. Ann Diagn Pathol. 2021;50:151660.
62. Noujaim J, Thway K, Sheri A, Keller C, Jones RL.Histology-driven therapy: the importance
of diagnostic accuracy in guiding systemic therapy of soft tissue tumors. Int J Surg Pathol.
2016;24(1):5–15.
63. Strobel O, Hackert T, Hartwig W, etal. Survival data justies resection for pancreatic metastases. Ann Surg Oncol. 2009;16(12):3340–9.
64. Ladenstein R, Potschger U, Le Deley MC, etal. Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol. 2010;28(20):3284–91.
65. Sperti C, Moletta L, Patane G.Metastatic tumors to the pancreas: the role of surgery. World J
Gastrointest Oncol. 2014;6(10):381–92.
R. Mudgway et al.

Part V
Surgical Technique—
Pancreatoduodenectomy

Chapter 19
Open Whipple
RachelC.Kim, JacksonA.Baril, andTrangK.Nguyen
Introduction andHistory
In 1898, Alessandro Codivilla attempted the rst documented radical pancreatoduodenectomy for an “epithelioma,” or carcinoma of the pancreas, when he was forced
to perform an en bloc resection rather than the preferred enucleation at that time
since the tumor was adherent to duodenum. Codivilla’s patient died from cachexia
21days after the procedure after experiencing wound drainage, “foul diarrhea,” and
eventually drainage of “milky clots,” likely from a pancreatic stula [1]. Soon after,
William Halsted was the rst to successfully resect a periampullary cancer, with a
transduodenal approach and performing a wedge resection with adjacent segments
of the pancreatic and common bile ducts, reimplanting both into the duodenum during the primary closure of the duodenal defect. The patient survived the operation,
although still died within a year due to local recurrence of the cancer [2].
In the following decades, there would be several advances in the eld of pancreatic surgery. Most notably, in 1935, Allen Oldfather Whipple, Surgeon-in-Chief at
Columbia-Presbyterian Medical Center, published his rst report on the radical
resection of the head of the pancreas and duodenum in three patients. His initial
technique was composed of a two-staged procedure, the rst consisting of a cholecystogastrostomy and posterior loop gastrojejunostomy, the second composed of
the partial duodenal and head of pancreas resection. The pancreatic stump was
occluded [3]. Whipple would continue to make advancements in his technique,
including condensing the surgery into a one-stage procedure, and in 1946, he
R. C. Kim · J. A. Baril
Department of Surgery, Indiana University School of Medicine, Indianapolis, IN, USA
e-mail: rckim@iu.edu; jbaril@iu.edu
T. K. Nguyen (
Division of Surgical Oncology, Washington University in St. Louis, St. Louis, MO, USA
e-mail: ntrang@wustl.edu
Switzerland AG 2025
E. P. Ceppa et al. (eds.), The SAGES Manual of Evolving Techniques in
Pancreatic Surgery, https://doi.org/10.1007/978-3-031-78409-5_19
*)
329© The Author(s), under exclusive license to Springer Nature

330
published his 10-year experience of 37 patients who underwent pancreaticoduodenectomy [4].
The Whipple operation was adapted and advanced outside of its eponym’s experience. For instance, Whipple was initially averse to reconstructing the pancreatic
duct, believing the anastomosis would place the other anastomoses at risk due to the
activation of pancreatic enzymes in the duodenum. However, this approach led to
frequent pancreatic stulas, and in 1941, Verne Hunt successfully incorporated a
pancreaticojejunostomy procedure to avoid pancreatic stump leakage [5]. This surgery of the pancreas also show high rates of marginal ulceration until the gastric
anastomosis was moved from the most proximal to the most distal of the anastomoses, and adequate gastrectomy was routinely practiced [6]. In 1978, Traverso and
Longmire reintroduced the idea of pylorus preservation, rst described by Kenneth
Watson in 1944, further reducing the frequency of marginal ulcers [7, 8]. The 1980s
and beyond saw the dramatic reduction in mortality rates following the Whipple
procedure from 20% to 40% to <5%, attributed to the centralization of this complex
operation to high-volume centers and pioneered under the leadership of John
Cameron at Johns Hopkins Hospital [9–11].
R. C. Kim et al.
Preoperative Considerations
Preoperative Work-Up andPlanning
All patients should undergo cross-sectional imaging prior to scheduled pancreatoduodenectomy, regardless of pathology. A high-quality CT “pancreas protocol” or
magnetic resonance imaging (MRI) is recommended to dene the anatomy. MRI
may be particularly useful in evaluating small (<2cm) pancreatic tumors and cystic
lesions. No data has suggested any advantage in obtaining both CT and MRI.
When reviewing imaging, attention should be directed specically toward
evaluating:
• Relationship of any lesion to surrounding major vascular vessels, including but
not limited to the superior mesenteric artery (SMA) and vein (SMV), portal vein
(PV), and celiac trunk and its branches, including the common hepatic
artery (CHA)
• Soft tissue planes, surfaces, and/or walls of the above major vessels for any dis-
tortion or other abnormality which may suggest tumor involvement
• Any anatomical variations, most commonly a replaced right hepatic artery origi-
nating from the SMA
• Any regional lymphadenopathy
• Hepatic lesions or other distant metastases
In addition to cross-sectional imaging, endoscopic evaluation is also commonly
used in the diagnostic and preoperative work-up for most pancreatic lesions.

19 Open Whipple
Endoscopic ultrasound (EUS) may be used to further characterize any lesion and
evaluate any signs of vascular invasion or distortion and may be superior to CT in
the detection of venous invasion specically [12, 13]. Surgeons should also keep in
mind that EUS quality and interpretation are operator dependent. Endoscopic retrograde cholangiopancreatography (ERCP) should be performed only if needed for
therapeutic purposes (e.g., obstructive jaundice, etc.), due to the risk for postprocedure pancreatitis. Endoscopic ultrasound or a DOTATATE-PET can be considered for patients with pancreatic neuroendocrine tumors to evaluate for
additional tumors.
331
Preoperative Assessment andManagement
Patients’ baseline functional status and medical comorbidities should be thoroughly
assessed and optimized as much as possible prior to surgery. Cardiac risk stratication should be performed if appropriate. Baseline pancreatic endocrine and exocrine
insufciency should also be assessed. It is also important to educate the patient on
perioperative expectations due to the high morbidity rate associated with the
Whipple operation. Perioperative assessment and postoperative complications after
pancreas surgery are discussed further in later chapters.
In the cases of malignancy, venous thromboembolism (VTE) prophylaxis is recommended for all patients with pancreatic cancer prior to surgery according to the
American Society of Clinical Oncology (ASCO) 2019 Clinical Practice Guidelines
[14]. However, while patients undergoing pancreatic resection for malignancy are
certainly at higher risk for VTE, this should be balanced against the risk of perioperative hemorrhage, and the evidence for the benet of preoperative VTE prophylaxis specic for hepatopancreatobiliary surgery remains inconsistent. The Americas
Hepato-Pancreato-Biliary Association (AHPBA) guidelines thus advocate for critical thinking when weighing the potential benets and risks of preoperative VTE
prophylaxis prior to major pancreatic surgery such as the Whipple [15].
Patient Positioning andSet Up
Patients should be assessed in the preoperative area for any recent changes in their
medical history. In the operating room, patients should be positioned supine with
arms either out or tucked, on an operating table capable of mounting appropriate
self-retaining retractors. When positioning the patient’s arms, attention should be
paid toward ensuring adequate room for the surgeon’s desired retractors to be connected to the table. Sequential compression devices or antithrombotic stockings
should be placed on the lower extremities. Appropriate preoperative antibiotic prophylaxis such as piperacillin-tazobactam should be administered prior to incision.

332
We recommend that the entire abdomen be prepped from approximately the nipple line to the level of the pubic symphysis. If a vascular resection with native graft
reconstruction is at all anticipated being considered, the relevant donor areas should
also be prepped.
R. C. Kim et al.
Key Steps
Staging Laparoscopy
Whether a staging laparoscopy is performed to assess for small hepatic or peritoneal
metastases in patients with malignancy is often dependent surgeon preference, as its
yield has decreased as the quality of cross-sectional imaging has improved, but it
still has a role in patients who are at increased risk for occult metastasis, such as in
those with markedly elevated serum CA 19-9.
Any suspicious lesion should be biopsied and sent for pathologic review to assess
for malignancy prior to proceed with the operation. Laparoscopic ultrasonography
of the liver can also be considered.
Exposure andDissection
Typically, an upper midline incision provides adequate exposure to the required
operative eld. Some surgeons prefer a bi-subcostal incision for patients with wide
and short torsos. Once the abdomen is accessed, the falciform ligament is ligated
distally and may be preserved to use as a pedicled falciform ap over the pancreaticojejunal anastomosis. Self-retaining retractors are placed until adequate and reliable exposure of the upper abdomen is achieved.
First, the hepatic exure is mobilized. A wide Kocher maneuver is then performed, mobilizing the duodenum off the retroperitoneal tissue to the ligament of
Treitz, exposing the inferior vena cava to the left renal vein. At this time, the SMA
can be palpated behind the pancreas to assess for tumor involvement. High-quality
cross-sectional imaging that shows no evidence of SMA involvement can render
this maneuver unnecessary.
Next, the lesser sac of the peritoneum is accessed. This can be achieved by either
dividing the gastrocolic ligament outside of the right gastroepiploic vessels or by
freeing the omentum off the transverse colon and mesocolon. The third portion of
the duodenum is then dissected free from the colonic mesentery and colon, fully
mobilizing the transverse colon inferiorly and off the duodenum until the inferior
edge of the pancreas and the SMV are exposed. In cases of pancreatic cancer, the
middle colic vein may be involved in the tumor, in which case this vessel can be
sacriced. Interchangeably, entrance to the lesser sac can be done before

ab
19 Open Whipple
333
Kocherization of the duodenum. At this point, the trunk of Henle can be used as a
landmark to trace the right gastroepiploic vein or the middle colic vein down to the
superior mesenteric vein (Fig. 19.1a). The caudal edge of the pancreas is then
exposed, and a retropancreatic tunnel is developed by blunt dissection between the
pancreatic neck and portal vein (PV)-SMV conuence. Dissection directly on top of
the middle of the PV-SMV conuence helps to stay in the avascular plane away
from the lateral branches on both sides.
Next, attention can be turned to the hepatoduodenal ligament dissection and creating the retropancreatic tunnel from above. A top-down approach is used for the
cholecystectomy. Caution should be taken to avoid the right hepatic artery, which
most commonly runs posterior to the hepatic duct, but in some patients may run
anteriorly. Additionally, as many as 10–15% of patients possess a replaced right
hepatic artery, which can be palpated in the hepatoduodenal ligament, and thus preoperative evaluation of the patient’s vascular anatomy on cross-sectional imaging is
critical (Figs.19.2 and 19.3) [18, 19].
Next, the portal triad is exposed and dissected. To achieve this, the peritoneal fat
over is removed, and in this process, the right gastric artery is divided. The common
hepatic artery (CHA) can be identied by the common hepatic artery node (station
8A), also known as “the node of importance.” The CHA is traced to the gastroduodenal artery (GDA) and proper hepatic artery. The GDA is then test clamped to
Fig. 19.1 (a) The trunk of Henle may be used to identify the SMV.Here, the right gastroepiploic
vein has been ligated where it drains into the SMV (black arrow and yellow vessel loop. *marks
pancreas) [16]. (b) A renal pedicle clamp traversing the retropancreatic tunnel, anterior along the
PV/SMV.A vessel loop is around the proper hepatic artery

334
ab
R. C. Kim et al.
ab c
Fig. 19.2 CT imaging demonstrating replaced right hepatic artery (RRHA) anatomic variations,
which should be evaluated carefully during preoperative work-up and planning. (a) RRHA coursing posterolateral to pancreatic head. (b) RRHA traversing the pancreatic head. (c) RRHA located
within the SMV groove [17]
Fig. 19.3 (a) Replaced common hepatic artery emerging between the common bile duct (left vessel loop) and portal vein. Top vessel loop—proper hepatic artery, bottom vessel loop—GDA. (b)
Following resection, the replaced common hepatic artery coming off the SMA and coursing over
the SMV/PV.Bulldog—divided hepatic duct. Sutures—pancreatic neck. Vein retractor—SMV
ascertain continued perfusion of the left and right hepatic arteries. At this point, the
GDA is ligated and divided. The common hepatic duct (CHD) is then identied and
dissected, and nally divided above the insertion of the cystic duct. A bulldog clamp
can be placed on the proximal CHD to prevent bile spillage.
The anterior surface of the portal vein should now be exposed posterior to the
GDA stump. The tunnel behind the pancreatic neck can now be completed from
above along the surface of the PV. Once the tunnel is completed, a vessel loop,
Соседние файлы в папке Библиотека им академика М.И. Перельмана
